{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:26:33Z","timestamp":1793820393138,"version":"4.6.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In light of the present therapeutic situation in COVID-19, any measure to improve course and outcome of seriously affected individuals is of utmost importance. We recap here evidence that supports the use of human recombinant erythropoietin (EPO) for ameliorating course and outcome of seriously ill COVID-19 patients. This brief expert review grounds on available subject-relevant literature searched until May 14, 2020, including Medline, Google Scholar, and preprint servers. We delineate in brief sections, each introduced by a summary of respective COVID-19 references, how EPO may target a number of the gravest sequelae of these patients. EPO is expected to: (1) improve respiration at several levels including lung, brainstem, spinal cord and respiratory muscles; (2) counteract overshooting inflammation caused by cytokine storm\/ inflammasome; (3) act neuroprotective and neuroregenerative in brain and peripheral nervous system. Based on this accumulating experimental and clinical evidence, we finally provide the research design for a double-blind placebo-controlled randomized clinical trial including severely affected patients, which is planned to start shortly.<\/jats:p>","DOI":"10.1186\/s10020-020-00186-y","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T17:03:01Z","timestamp":1592326981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Erythropoietin as candidate for supportive treatment of severe COVID-19"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8371-5711","authenticated-orcid":false,"given":"Hannelore","family":"Ehrenreich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Weissenborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Begemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilla W.","family":"Miskowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"issue":"4","key":"186_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.immuni.2009.02.005","volume":"30","author":"IC Allen","year":"2009","unstructured":"Allen IC, Scull MA, Moore CB, et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza a virus through recognition of viral RNA. Immunity. 2009;30(4):556\u201365.","journal-title":"Immunity."},{"issue":"15","key":"186_CR2","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1073\/pnas.87.15.5978","volume":"87","author":"A Anagnostou","year":"1990","unstructured":"Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A. 1990;87(15):5978\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"186_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/CCM.0b013e31819b8371","volume":"37","author":"K Aoshiba","year":"2009","unstructured":"Aoshiba K, Onizawa S, Tsuji T, Nagai A. Therapeutic effects of erythropoietin in murine models of endotoxin shock. Crit Care Med. 2009;37(3):889\u201398.","journal-title":"Crit Care Med"},{"key":"186_CR4","doi-asserted-by":"crossref","unstructured":"Avula A, Nalleballe K, Narula N, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020.","DOI":"10.1016\/j.bbi.2020.04.077"},{"issue":"5","key":"186_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cns.13372","volume":"26","author":"AM Baig","year":"2020","unstructured":"Baig AM. Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS Neurosci Ther. 2020;26(5):499\u2013501.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"186_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/1756285608098422","volume":"1","author":"C Bartels","year":"2008","unstructured":"Bartels C, Spate K, Krampe H, Ehrenreich H. Recombinant human erythropoietin: novel strategies for neuroprotective\/neuro-regenerative treatment of multiple sclerosis. Ther Adv Neurol Disord. 2008;1(3):193\u2013206.","journal-title":"Ther Adv Neurol Disord"},{"key":"186_CR7","doi-asserted-by":"crossref","unstructured":"Bauchner H, Fontanarosa PB. Randomized clinical trials and COVID-19: managing expectations. JAMA. 2020.","DOI":"10.1001\/jama.2020.8115"},{"issue":"6","key":"186_CR8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrn1687","volume":"6","author":"M Brines","year":"2005","unstructured":"Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci. 2005;6(6):484\u201394.","journal-title":"Nat Rev Neurosci"},{"key":"186_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fphar.2020.00306","volume":"11","author":"F Cao","year":"2020","unstructured":"Cao F, Tian X, Li Z, et al. Suppression of NLRP3 Inflammasome by erythropoietin via the EPOR\/JAK2\/STAT3 pathway contributes to attenuation of acute lung injury in mice. Front Pharmacol. 2020;11:306.","journal-title":"Front Pharmacol"},{"issue":"5","key":"186_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269\u201370.","journal-title":"Nat Rev Immunol"},{"key":"186_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.resp.2014.11.012","volume":"206","author":"C Caravagna","year":"2015","unstructured":"Caravagna C, Soliz J. PI3K and MEK1\/2 molecular pathways are involved in the erythropoietin-mediated regulation of the central respiratory command. Respir Physiol Neurobiol. 2015;206:36\u201340.","journal-title":"Respir Physiol Neurobiol"},{"key":"186_CR12","doi-asserted-by":"crossref","unstructured":"Casadevall A, Joyner MJ, Pirofski LA. A randomized trial of convalescent plasma for COVID-19-potentially hopeful signals. JAMA. 2020.","DOI":"10.1001\/jama.2020.10218"},{"issue":"4","key":"186_CR13","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/01.CCM.0000207346.56477.E8","volume":"34","author":"S Cuzzocrea","year":"2006","unstructured":"Cuzzocrea S, Di Paola R, Mazzon E, et al. Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice. Crit Care Med. 2006;34(4):1168\u201377.","journal-title":"Crit Care Med"},{"issue":"17","key":"186_CR14","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.1523\/JNEUROSCI.3873-11.2012","volume":"32","author":"EA Dale","year":"2012","unstructured":"Dale EA, Satriotomo I, Mitchell GS. Cervical spinal erythropoietin induces phrenic motor facilitation via extracellular signal-regulated protein kinase and Akt signaling. J Neurosci. 2012;32(17):5973\u201383.","journal-title":"J Neurosci"},{"issue":"14","key":"186_CR15","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1001\/jama.2020.3072","volume":"323","author":"C Del Rio","year":"2020","unstructured":"Del Rio C, Malani PN. COVID-19-new insights on a rapidly changing epidemic. JAMA. 2020;323(14):1339\u201340.","journal-title":"JAMA."},{"key":"186_CR16","doi-asserted-by":"crossref","unstructured":"Desforges M, Le Coupanec A, Dubeau P, et al. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses. 2019;12(1).","DOI":"10.3390\/v12010014"},{"issue":"9","key":"186_CR17","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1073\/pnas.92.9.3717","volume":"92","author":"M Digicaylioglu","year":"1995","unstructured":"Digicaylioglu M, Bichet S, Marti HH, et al. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci U S A. 1995;92(9):3717\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"186_CR18","doi-asserted-by":"publisher","first-page":"e00404","DOI":"10.1128\/JVI.00404-18","volume":"92","author":"M Dube","year":"2018","unstructured":"Dube M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, Talbot PJ. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018;92(17):e00404\u201318.","journal-title":"J Virol"},{"issue":"Pt 10","key":"186_CR19","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1093\/brain\/awm203","volume":"130","author":"H Ehrenreich","year":"2007","unstructured":"Ehrenreich H, Fischer B, Norra C, et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain. 2007a;130(Pt 10):2577\u201388.","journal-title":"Brain."},{"issue":"8","key":"186_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF03402029","volume":"8","author":"H Ehrenreich","year":"2002","unstructured":"Ehrenreich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002;8(8):495\u2013505.","journal-title":"Mol Med"},{"issue":"2","key":"186_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/sj.mp.4001907","volume":"12","author":"H Ehrenreich","year":"2007","unstructured":"Ehrenreich H, Hinze-Selch D, Stawicki S, et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry. 2007b;12(2):206\u201320.","journal-title":"Mol Psychiatry"},{"issue":"19","key":"186_CR22","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMc2002493","volume":"382","author":"H Ehrenreich","year":"2020","unstructured":"Ehrenreich H, Neubauer AP, Miskowiak K. Erythropoietin in preterm infants. N Engl J Med. 2020;382(19):1862.","journal-title":"N Engl J Med"},{"issue":"12","key":"186_CR23","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","volume":"40","author":"H Ehrenreich","year":"2009","unstructured":"Ehrenreich H, Weissenborn K, Prange H, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40(12):e647\u201356.","journal-title":"Stroke."},{"issue":"1","key":"186_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10156-003-0296-9","volume":"10","author":"T Fujii","year":"2004","unstructured":"Fujii T, Nakamura T, Iwamoto A. Current concepts in SARS treatment. J Infect Chemother. 2004;10(1):1\u20137.","journal-title":"J Infect Chemother"},{"key":"186_CR25","doi-asserted-by":"crossref","unstructured":"Gandhi S, Srivastava AK, Ray U, Tripathi PP. Is the collapse of the respiratory Center in the Brain Responsible for respiratory breakdown in COVID-19 patients? ACS Chem Neurosci. 2020.","DOI":"10.1021\/acschemneuro.0c00217"},{"key":"186_CR26","doi-asserted-by":"crossref","unstructured":"Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020.","DOI":"10.1056\/NEJMc2010419"},{"key":"186_CR27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.12688\/f1000research.8723.1","volume":"5","author":"G Grasso","year":"2016","unstructured":"Grasso G, Alafaci C, Ghezzi P. Is erythropoietin a worthy candidate for traumatic brain injury or are we heading the wrong way? F1000Res. 2016;5:911.","journal-title":"F1000Res"},{"key":"186_CR28","unstructured":"Grein J, Ohmagari N, Shin D, et al. Compassionate use of Remdesivir for patients with severe Covid-19. N Engl J Med. 2020."},{"key":"186_CR29","doi-asserted-by":"crossref","unstructured":"Gross O, Moerer O, Weber M, Huber TB, Scheithauer S. COVID-19-associated nephritis: early warning for disease severity and complications? Lancet. 2020; in press.","DOI":"10.1016\/S0140-6736(20)31041-2"},{"issue":"3","key":"186_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1084\/jem.20050828","volume":"202","author":"J Gu","year":"2005","unstructured":"Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415\u201324.","journal-title":"J Exp Med"},{"issue":"4","key":"186_CR31","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","volume":"170","author":"J Gu","year":"2007","unstructured":"Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007;170(4):1136\u201347.","journal-title":"Am J Pathol"},{"key":"186_CR32","doi-asserted-by":"crossref","unstructured":"Hadadi A, Mortezazadeh M, Kolahdouzan K, Alavian G. Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J Med Virol. 2020.","DOI":"10.1002\/jmv.25839"},{"key":"186_CR33","doi-asserted-by":"crossref","unstructured":"Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020.","DOI":"10.1056\/NEJMc2008597"},{"issue":"10","key":"186_CR34","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","volume":"19","author":"MT Heneka","year":"2018","unstructured":"Heneka MT, McManus RM, Latz E. Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci. 2018;19(10):610\u201321.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"186_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3346\/jkms.2014.29.3.416","volume":"29","author":"K Heo","year":"2014","unstructured":"Heo K, Kang JK, Choi CM, Lee MS, Noh KW, Kim SB. Prophylactic effect of erythropoietin injection to prevent acute mountain sickness: an open-label randomized controlled trial. J Korean Med Sci. 2014;29(3):416\u201322.","journal-title":"J Korean Med Sci"},{"key":"186_CR36","doi-asserted-by":"crossref","unstructured":"Ivanov K, Garanina E, Rizvanov A, Khaiboullina S. Inflammasomes as Targets for Adjuvants. Pathogens. 2020;9(4).","DOI":"10.3390\/pathogens9040252"},{"issue":"2","key":"186_CR37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1152\/physrev.1992.72.2.449","volume":"72","author":"W Jelkmann","year":"1992","unstructured":"Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev. 1992;72(2):449\u201389.","journal-title":"Physiol Rev"},{"issue":"6","key":"186_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000441799","volume":"90","author":"P Jungebluth","year":"2015","unstructured":"Jungebluth P, Holzgraefe B, Lim ML, et al. Autologous peripheral blood mononuclear cells as treatment in refractory acute respiratory distress syndrome. Respiration. 2015;90(6):481\u201392.","journal-title":"Respiration."},{"issue":"1","key":"186_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00228-010-0938-7","volume":"67","author":"S Kakavas","year":"2011","unstructured":"Kakavas S, Demestiha T, Vasileiou P, Xanthos T. Erythropoetin as a novel agent with pleiotropic effects against acute lung injury. Eur J Clin Pharmacol. 2011;67(1):1\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"186_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/blood.V77.3.419.419","volume":"77","author":"SB Krantz","year":"1991","unstructured":"Krantz SB. Erythropoietin. Blood. 1991;77(3):419\u201334.","journal-title":"Blood"},{"key":"186_CR41","doi-asserted-by":"crossref","unstructured":"Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020; In press.","DOI":"10.1016\/S2352-3026(20)30145-9"},{"key":"186_CR42","unstructured":"Li L, Zhang W, Hu Y, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA. 2020a."},{"issue":"6","key":"186_CR43","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jmv.25728","volume":"92","author":"YC Li","year":"2020","unstructured":"Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020b;92(6):552\u20135.","journal-title":"J Med Virol"},{"issue":"1","key":"186_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/cne.23171","volume":"521","author":"YC Li","year":"2013","unstructured":"Li YC, Bai WZ, Hirano N, et al. Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication. J Comp Neurol. 2013;521(1):203\u201312.","journal-title":"J Comp Neurol"},{"key":"186_CR45","doi-asserted-by":"crossref","unstructured":"Liao M, Liu Y, Yuan J, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020; In press.","DOI":"10.1038\/s41591-020-0901-9"},{"issue":"9","key":"186_CR46","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s00134-019-05686-y","volume":"45","author":"E Litton","year":"2019","unstructured":"Litton E, Latham P, Inman J, Luo J, Allan P. Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis. Intensive Care Med. 2019;45(9):1190\u20139.","journal-title":"Intensive Care Med"},{"issue":"14","key":"186_CR47","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1056\/NEJMc2003717","volume":"382","author":"W Liu","year":"2020","unstructured":"Liu W, Zhang Q, Chen J, et al. Detection of Covid-19 in children in early January 2020 in Wuhan, China. N Engl J Med. 2020;382(14):1370\u20131.","journal-title":"N Engl J Med"},{"key":"186_CR48","first-page":"142","volume-title":"How the SARS coronavirus causes disease: host or organism?","author":"AW Lo","year":"2006","unstructured":"Lo AW, Tang NL, To KF. In: Herrington CS, Douek DC, editors. How the SARS coronavirus causes disease: host or organism? vol. 208. Chichester: Wiley; 2006. p. 142\u201351."},{"key":"186_CR49","doi-asserted-by":"crossref","unstructured":"Lucchese G, Floel A. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons. Autoimmun Rev. 2020;102556.","DOI":"10.1016\/j.autrev.2020.102556"},{"key":"186_CR50","doi-asserted-by":"publisher","first-page":"12177","DOI":"10.1038\/ncomms12177","volume":"7","author":"B Luo","year":"2016","unstructured":"Luo B, Wang J, Liu Z, et al. Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution. Nat Commun. 2016;7:12177.","journal-title":"Nat Commun"},{"key":"186_CR51","doi-asserted-by":"crossref","unstructured":"Lythgoe MP, Middleton P. Ongoing clinical trials for the management of the COVID-19 pandemic. Trends Pharmacol Sci. 2020.","DOI":"10.1016\/j.tips.2020.03.006"},{"issue":"6","key":"186_CR52","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1183\/09031936.00084608","volume":"33","author":"R MacRedmond","year":"2009","unstructured":"MacRedmond R, Singhera GK, Dorscheid DR. Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury. Eur Respir J. 2009;33(6):1403\u201314.","journal-title":"Eur Respir J"},{"key":"186_CR53","doi-asserted-by":"crossref","unstructured":"Magagnoli JNA, Periera F, Cummings T, Hardin JW, Pharm SS, Ambati J. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. MedRxiv The preprint Server for Health Sciences. 2020.","DOI":"10.1101\/2020.04.16.20065920"},{"key":"186_CR54","doi-asserted-by":"crossref","unstructured":"Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020.","DOI":"10.1001\/jamaneurol.2020.1127"},{"issue":"4","key":"186_CR55","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1460-9568.1996.tb01252.x","volume":"8","author":"HH Marti","year":"1996","unstructured":"Marti HH, Wenger RH, Rivas LA, et al. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci. 1996;8(4):666\u201376.","journal-title":"Eur J Neurosci"},{"key":"186_CR56","doi-asserted-by":"crossref","unstructured":"Mehta P, Cron RQ, Hartwell J, Manson JJ, Tattersall RS. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol. 2020a.","DOI":"10.1016\/S2665-9913(20)30096-5"},{"issue":"10229","key":"186_CR57","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020b;395(10229):1033\u20134.","journal-title":"Lancet."},{"issue":"8","key":"186_CR58","volume":"8","author":"B Mesgarpour","year":"2017","unstructured":"Mesgarpour B, Heidinger BH, Roth D, Schmitz S, Walsh CD, Herkner H. Harms of off-label erythropoiesis-stimulating agents for critically ill people. Cochrane Database Syst Rev. 2017;8(8):CD010969.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"186_CR59","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.4088\/JCP.13m08839","volume":"75","author":"KW Miskowiak","year":"2014","unstructured":"Miskowiak KW, Ehrenreich H, Christensen EM, Kessing LV, Vinberg M. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J Clin Psychiatry. 2014a;75(12):1347\u201355.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"186_CR60","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/npp.2013.335","volume":"39","author":"KW Miskowiak","year":"2014","unstructured":"Miskowiak KW, Vinberg M, Christensen EM, et al. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial. Neuropsychopharmacology. 2014b;39(6):1399\u2013408.","journal-title":"Neuropsychopharmacology."},{"issue":"4","key":"186_CR61","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.biopsych.2014.12.013","volume":"78","author":"KW Miskowiak","year":"2015","unstructured":"Miskowiak KW, Vinberg M, Macoveanu J, et al. Effects of erythropoietin on hippocampal volume and memory in mood disorders. Biol Psychiatry. 2015;78(4):270\u20137.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"186_CR62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2377-11-37","volume":"11","author":"H Moldofsky","year":"2011","unstructured":"Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11(1):37.","journal-title":"BMC Neurol"},{"key":"186_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","volume":"94","author":"T Moriguchi","year":"2020","unstructured":"Moriguchi T, Harii N, Goto J, et al. A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55\u20138.","journal-title":"Int J Infect Dis"},{"key":"186_CR64","doi-asserted-by":"crossref","unstructured":"Munster V, Feldmann F, Williamson B, et al. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 2020; In press.","DOI":"10.1101\/2020.03.21.001628"},{"key":"186_CR65","doi-asserted-by":"crossref","unstructured":"Nath A. Neurologic complications of coronavirus infections. Neurology. 2020.","DOI":"10.1201\/9781315113913-34"},{"issue":"15","key":"186_CR66","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1128\/JVI.00737-08","volume":"82","author":"J Netland","year":"2008","unstructured":"Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264\u201375.","journal-title":"J Virol"},{"key":"186_CR67","doi-asserted-by":"crossref","unstructured":"Oxley TJ, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020.","DOI":"10.1056\/NEJMc2009787"},{"issue":"1","key":"186_CR68","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1203\/01.PDR.0000163391.75389.52","volume":"58","author":"EA Ozer","year":"2005","unstructured":"Ozer EA, Kumral A, Ozer E, et al. Effects of erythropoietin on hyperoxic lung injury in neonatal rats. Pediatr Res. 2005;58(1):38\u201341.","journal-title":"Pediatr Res"},{"key":"186_CR69","doi-asserted-by":"crossref","unstructured":"Paranjpe I, Fuster V, Lala A, et al. Association of Treatment Dose Anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020.","DOI":"10.1016\/j.jacc.2020.05.001"},{"issue":"2","key":"186_CR70","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-020-2276-8","volume":"11","author":"B Peng","year":"2020","unstructured":"Peng B, Kong G, Yang C, Ming Y. Erythropoietin and its derivatives: from tissue protection to immune regulation. Cell Death Dis. 2020;11(2):79.","journal-title":"Cell Death Dis"},{"key":"186_CR71","doi-asserted-by":"crossref","unstructured":"Perico L, Benigni A, Remuzzi G. Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron. 2020:1\u20139.","DOI":"10.1159\/000507305"},{"issue":"1","key":"186_CR72","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s10753-014-0035-7","volume":"38","author":"J Rocha","year":"2015","unstructured":"Rocha J, Eduardo-Figueira M, Barateiro A, et al. Erythropoietin reduces acute lung injury and multiple organ failure\/dysfunction associated to a scald-burn inflammatory injury in the rat. Inflammation. 2015;38(1):312\u201326.","journal-title":"Inflammation."},{"issue":"8","key":"186_CR73","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1073\/pnas.95.8.4635","volume":"95","author":"M Sakanaka","year":"1998","unstructured":"Sakanaka M, Wen TC, Matsuda S, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A. 1998;95(8):4635\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"186_CR74","doi-asserted-by":"crossref","unstructured":"Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020.","DOI":"10.1001\/jama.2020.6019"},{"issue":"4","key":"186_CR75","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.bpa.2010.10.005","volume":"24","author":"D Sargin","year":"2010","unstructured":"Sargin D, Friedrichs H, El-Kordi A, Ehrenreich H. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaesthesiol. 2010;24(4):573\u201394.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"1","key":"186_CR76","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jss.2008.10.003","volume":"155","author":"Y Shang","year":"2009","unstructured":"Shang Y, Li X, Prasad PV, et al. Erythropoietin attenuates lung injury in lipopolysaccharide treated rats. J Surg Res. 2009;155(1):104\u201310.","journal-title":"J Surg Res"},{"issue":"24","key":"186_CR77","doi-asserted-by":"publisher","first-page":"9733","DOI":"10.1523\/JNEUROSCI.21-24-09733.2001","volume":"21","author":"T Shingo","year":"2001","unstructured":"Shingo T, Sorokan ST, Shimazaki T, Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci. 2001;21(24):9733\u201343.","journal-title":"J Neurosci"},{"key":"186_CR78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.resp.2016.10.011","volume":"236","author":"CA Silva","year":"2017","unstructured":"Silva CA, Vicente MC, Tenorio-Lopes L, Soliz J, Gargaglioni LH. Erythropoietin in the locus coeruleus attenuates the ventilatory response to CO2 in rats. Respir Physiol Neurobiol. 2017;236:11\u20138.","journal-title":"Respir Physiol Neurobiol"},{"issue":"9","key":"186_CR79","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1097\/01.CCM.0000233873.17954.42","volume":"34","author":"M Silver","year":"2006","unstructured":"Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. Crit Care Med. 2006;34(9):2310\u20136.","journal-title":"Crit Care Med"},{"issue":"1","key":"186_CR80","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.nurt.2008.10.041","volume":"6","author":"AL Siren","year":"2009","unstructured":"Siren AL, Fasshauer T, Bartels C, Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics. 2009;6(1):108\u201327.","journal-title":"Neurotherapeutics."},{"issue":"6","key":"186_CR81","doi-asserted-by":"publisher","first-page":"R1837","DOI":"10.1152\/ajpregu.90967.2008","volume":"296","author":"J Soliz","year":"2009","unstructured":"Soliz J, Thomsen JJ, Soulage C, Lundby C, Gassmann M. Sex-dependent regulation of hypoxic ventilation in mice and humans is mediated by erythropoietin. Am J Physiol Regul Integr Comp Physiol. 2009;296(6):R1837\u201346.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"186_CR82","first-page":"e13473","volume-title":"Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19","author":"L Steardo","year":"2020","unstructured":"Steardo L, Zorec R, Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19; 2020. p. e13473."},{"key":"186_CR83","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3389\/fphys.2019.01534","volume":"10","author":"S Suresh","year":"2019","unstructured":"Suresh S, Rajvanshi PK, Noguchi CT. The many facets of erythropoietin physiologic and metabolic response. Front Physiol. 2019;10:1534.","journal-title":"Front Physiol"},{"issue":"46","key":"186_CR84","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.3748\/wjg.v13.i46.6172","volume":"13","author":"O Tascilar","year":"2007","unstructured":"Tascilar O, Cakmak GK, Tekin IO, et al. Protective effects of erythropoietin against acute lung injury in a rat model of acute necrotizing pancreatitis. World J Gastroenterol. 2007;13(46):6172\u201382.","journal-title":"World J Gastroenterol"},{"key":"186_CR85","doi-asserted-by":"crossref","unstructured":"Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barre syndrome associated with SARS-CoV-2. N Engl J Med. 2020.","DOI":"10.1056\/NEJMc2009191"},{"key":"186_CR86","doi-asserted-by":"crossref","unstructured":"Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain, Behav Immunity. 2020.","DOI":"10.1016\/j.bbi.2020.04.027"},{"issue":"1","key":"186_CR87","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/s41467-020-15041-1","volume":"11","author":"D Wakhloo","year":"2020","unstructured":"Wakhloo D, Scharkowski F, Curto Y, et al. Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin. Nat Commun. 2020;11(1):1313.","journal-title":"Nat Commun"},{"key":"186_CR88","doi-asserted-by":"crossref","unstructured":"Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020b;323(11).","DOI":"10.1001\/jama.2020.1585"},{"key":"186_CR89","doi-asserted-by":"crossref","unstructured":"Wang X, Xu W, Hu G, et al. SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell Mol Immunol. 2020a.","DOI":"10.1038\/s41423-020-0424-9"},{"key":"186_CR90","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","volume":"6","author":"W Wen","year":"2020","unstructured":"Wen W, Su W, Tang H, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6:31.","journal-title":"Cell Discov"},{"key":"186_CR91","volume-title":"COVID-19: potential benefits of erythropoietin","author":"D Wincewicz","year":"2020","unstructured":"Wincewicz D, Miskowiak KW, Vieta E. COVID-19: potential benefits of erythropoietin. (in review). 2020."},{"issue":"8","key":"186_CR92","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1161\/STROKEAHA.113.001145","volume":"44","author":"H Worthmann","year":"2013","unstructured":"Worthmann H, Martens-Lobenhoffer J, Joumaah M, et al. Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke. Stroke. 2013;44(8):2128\u201333.","journal-title":"Stroke."},{"issue":"2\u20133","key":"186_CR93","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ejphar.2008.11.037","volume":"602","author":"H Wu","year":"2009","unstructured":"Wu H, Dong G, Liu H, Xu B, Li D, Jing H. Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression. Eur J Pharmacol. 2009;602(2\u20133):406\u201312.","journal-title":"Eur J Pharmacol"},{"key":"186_CR94","doi-asserted-by":"crossref","unstructured":"Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020.","DOI":"10.1016\/j.bbi.2020.03.031"},{"key":"186_CR95","doi-asserted-by":"crossref","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020.","DOI":"10.1001\/jama.2020.2648"},{"issue":"1","key":"186_CR96","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/mp.2010.51","volume":"16","author":"T Wustenberg","year":"2011","unstructured":"Wustenberg T, Begemann M, Bartels C, et al. Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Mol Psychiatry. 2011;16(1):26\u201336 21.","journal-title":"Mol Psychiatry"},{"key":"186_CR97","doi-asserted-by":"crossref","unstructured":"Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020.","DOI":"10.1016\/S2213-2600(20)30079-5"},{"issue":"6","key":"186_CR98","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/01.TA.0000169803.09482.F8","volume":"58","author":"E Yildirim","year":"2005","unstructured":"Yildirim E, Ozisik K, Solaroglu I, et al. Protective effect of erythropoietin on type II pneumocyte cells after traumatic brain injury in rats. J Trauma. 2005;58(6):1252\u20138.","journal-title":"J Trauma"},{"issue":"17","key":"186_CR99","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and Antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38.","journal-title":"N Engl J Med"},{"issue":"3","key":"186_CR100","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.transproceed.2019.01.059","volume":"51","author":"M Zhu","year":"2019","unstructured":"Zhu M, Wang L, Yang J, et al. Erythropoietin ameliorates lung injury by accelerating pulmonary endothelium cell proliferation via Janus kinase-signal transducer and activator of transcription 3 pathway after kidney ischemia and reperfusion injury. Transplant Proc. 2019;51(3):972\u20138.","journal-title":"Transplant Proc"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-020-00186-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-020-00186-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-020-00186-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T21:52:12Z","timestamp":1666993932000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-020-00186-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1186\/s10020-020-00186-y","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors report no conflict of interest related to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}